Skip to content

marketing-in-your-industryhealthcare

How to Choose a Healthcare Marketing Agency: A 2026 Guide

Healthcare marketing carries legal exposure most agencies have never had to manage. Here is the evaluation framework that actually separates operators who get it from the ones who will learn on your dime.

A scalpel lies next to a red wax seal pressed onto a folded white cloth on a metal tray.
Illustration by CMO Mag

Key takeaways

  • Ask any healthcare marketing agency to name the last time they signed a Business Associate Agreement and what triggered it. If they hesitate, they have not done real PHI-adjacent work.
  • The contract should specify who owns ad account admin access, first-party data, and creative files on termination, not just deliverables and price.
  • Build a 30/60/90 day plan with named checkpoints before you sign, so you find out in week 45 whether it is working, not month 14.
  • Two federal settlements, BetterHelp's $7.8 million and GoodRx's $1.5 million, show regulators now treat health-adjacent ad targeting as a data privacy violation, not a marketing footnote.
  • Weight the proposal's compliance language as heavily as its creative work. An agency that skips HIPAA marketing provisions entirely is telling you something.

Why this hire is different

I have talked to four healthcare CMOs this year who fired their agency inside twelve months of signing, and in every case the breakup had nothing to do with creative quality. It was a targeting decision the agency made without asking, a reporting dashboard that quietly commingled patient data with ad platform pixels, or a contract that left the client with no ad account access when the relationship ended. None of those failures show up in a pitch deck. They show up six months in, when the compliance officer asks a question nobody can answer.

Healthcare marketing sits inside a regulatory box that most consumer agencies have never had to think about. HIPAA's marketing provisions restrict how protected health information can be used to promote products or services, and the HHS guidance on marketing is specific about when patient authorization is required. Layer on FTC enforcement of the Health Breach Notification Rule, state-level advertising restrictions for certain specialties, and platform-level ad policies that treat health conditions as sensitive categories, and you get a discipline where the wrong pixel can become a federal case.

$7.8M

FTC settlement with BetterHelp over sharing patients' mental health data for ad targeting

Federal Trade Commission, 2023

$1.5M

FTC penalty against GoodRx, the first enforcement action under the Health Breach Notification Rule

Federal Trade Commission, 2023

The questions that actually expose understanding

Every agency will tell you they have healthcare experience. Most mean they made a hospital system's Facebook ads look nice. The questions below are designed to separate genuine operators from generalists wearing a healthcare logo slide.

  • When did you last sign a Business Associate Agreement, and what triggered it? A real answer names a specific data flow, not a boilerplate policy.
  • Walk me through a campaign you had to kill or redesign because of an advertising restriction. Vague answers here mean they have never actually hit the wall.
  • How do you handle retargeting for service lines that touch sensitive conditions, like behavioral health, oncology or fertility? The honest answer usually involves saying no to something a client wanted.
  • What is your process when a state's advertising rules for a specific specialty (dental, chiropractic, addiction treatment) conflict with a national campaign template?
  • Which ad platforms have you had rejected or flagged for health-related creative, and how did you fix it?
An agency that has never had a campaign rejected for a compliance reason has probably never run one that mattered.
Tom Gallagher

Listen for specificity, not confidence. Confident generalities are cheap. A team that can describe the exact moment a client's legal counsel pulled a campaign, and what changed afterward, has actually done the work. If you're building a broader shortlist, the overview of leading firms in this category is a reasonable starting point, but treat any list, including that one, as a filter for questions, not a final answer.

For a wider view of how firms in this space are typically evaluated, the framework in our buyer's guide to healthcare marketing companies is a useful companion to this piece, though it is not a substitute for asking your own version of these questions.

Reading the proposal for what it doesn't say

A proposal that opens with brand voice and closes with a media plan, and never mentions data handling, consent, or compliance review, was written by a team that treats healthcare as a vertical flavor rather than a constraint. Compliance language should show up in the methodology section, not as an appendix bolted on after legal flagged it.

Push for specifics on measurement, too. If the proposal promises attribution across the funnel without addressing how patient-level data gets anonymized or excluded from ad platform feeds, that's a gap that will surface later as a compliance incident, not a reporting nuance. Our breakdown of attribution models is worth reviewing before you evaluate any agency's measurement pitch, because the wrong model choice compounds the data-handling risk rather than isolating it.

That audit discipline matters regardless of vertical. The step-by-step process in our martech stack audit guide applies directly here: know every tool touching patient-adjacent data before an agency plugs it into your ecosystem.

What belongs in the contract

The contract is where good intentions either become enforceable obligations or evaporate the first time there's a dispute. Beyond scope and price, a healthcare marketing agreement needs to specify four things explicitly, in writing, before either side signs.

  1. A signed Business Associate Agreement if the agency will touch any protected health information, even indirectly through analytics or CRM integrations.
  2. Data ownership terms stating that patient data, first-party audience data, and campaign performance data belong to the client, full stop, with export rights on request at any time.
  3. Ad account and platform admin ownership, meaning the client holds the primary account, not the agency, so nothing evaporates on termination.
  4. A termination clause with a defined handoff period (30 to 45 days is typical) and a list of deliverables the agency must transfer: creative files, tracking pixels, campaign history, and documentation of any data-sharing setups.

That third point trips up more marketing leaders than any other. I've watched a health system lose two years of campaign history and audience segments because the agency had built everything inside its own ad manager account, and the relationship ended badly. Get this in writing before the kickoff call, not after the first disagreement.

Reporting you can actually trust

Monthly decks with vanity metrics are the default output of an agency that isn't confident in its own numbers. Insist on a reporting cadence that ties spend to a defined business outcome, whether that's qualified appointment requests, patient portal signups, or service-line volume, and require raw data access alongside the dashboard, not instead of it.

This is also where a first-party data strategy matters more than it did five years ago. As third-party cookies erode further, the practical roadmap for first-party data lays out why healthcare marketers in particular need to own their measurement infrastructure rather than renting it from a vendor who might also be your agency.

Structuring the first 90 days

The goal of the first 90 days isn't a full campaign launch. It's finding out, early and cheaply, whether the agency's stated capabilities match its actual behavior under real conditions. Build named checkpoints into the statement of work before signing, so there's no ambiguity about what success looks like at each stage.

A 30/60/90 day evaluation framework for a new healthcare marketing agency
CheckpointWhat to verify
Day 30BAA signed and filed. Data flow map delivered showing every tool touching patient-adjacent data. Ad accounts set up under client ownership.
Day 60First campaign live with agreed measurement in place. Reporting ties to a defined business metric, not just impressions or clicks.
Day 90Full reporting review against the original proposal's stated capabilities. Compliance incident log reviewed, even if empty. Decision point on renewal or off-ramp.
Framework based on standard marketing agency onboarding practice

If the agency resists building these checkpoints into the contract, that resistance is itself information. A team confident in its own process should welcome a structured early exit ramp, because it protects both sides from a slow, expensive mismatch. Set a hard date for the 90-day review on the calendar the day you sign, not the day someone remembers to schedule it.

None of this replaces the basic leadership discipline of knowing what you're accountable for internally. If your own mandate is fuzzy, an agency will happily fill the gap with its own priorities. Revisit what a CMO's role and reporting lines actually look like before the search starts, so the agency is answering to a clear scorecard rather than a vague sense of 'growth.'

Get more sector-specific playbooks for marketing leaders in regulated industries.

Frequently asked questions

Ask when they last signed a Business Associate Agreement and what data flow triggered it, ask them to describe a campaign they had to kill or redesign for a compliance reason, and ask which ad platforms have flagged or rejected their health-related creative. Vague or generic answers to any of these signal an agency that hasn't actually operated under these constraints.

Look for specificity, not confidence. An agency that understands healthcare can name a real regulatory conflict it navigated, describe how it handles retargeting for sensitive service lines, and discuss HIPAA marketing provisions and data-sharing agreements as part of its default methodology, not as an afterthought added when legal asks.

Beyond scope and pricing, insist on a signed Business Associate Agreement where PHI is involved, explicit client ownership of first-party data and ad platform admin access, and a termination clause with a defined handoff period covering creative files, tracking setups, and campaign history transfer.

Portrait of Tom Gallagher

Tom Gallagher

AI expert · Verified

Marketing leadership writer · marketing-in-your-industry

Tom Gallagher has sat in the CMO chair and knows how lonely it can be. He led marketing organizations through growth, cuts, and reinvention. He writes about the CMO role, budgets, and building marketing teams — candid about the parts of the job nobody warns you about.

More from Tom Gallagher What is an AI expert?

Advertiser disclosure: some links in our articles are affiliate links, and CMO Mag may earn a commission or referral fee if you sign up or buy through them, at no cost to you. It never affects our editorial coverage. See our advertising & affiliate policy.

Discussion

No comments yet. Be the first to say something worth reading.

View all

The CMO Mag brief

The marketing intelligence worth reading

Get the numbers behind the news. Pick your cadence.